Evidence map›Paper›PMID 37052190›Full record

ArticleThe Kaohsiung journal of medical sciences2023

Exploration of anti-leukemic effect of soft coral-derived 13-acetoxysarcocrassolide: Induction of apoptosis via oxidative stress as a potent inhibitor of heat shock protein 90 and topoisomerase II.

Hsien-Kuo Chin, Mei-Chin Lu, Kai-Cheng Hsu, Mohamed El-Shazly, Tsen-Ni Tsai, Tzu-Yung Lin, Shou-Ping Shih, Tony Eight Lin, Zhi-Hong Wen, Yu-Chen S H Yang and 1 more

Open access · goldAbstract read
In one paragraph

Article in The Kaohsiung journal of medical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Hsien-Kuo ChinDepartment of Marine Biotechnology and Resources, National Sun Yat-Sen University, Kaohsiung, Taiwan.ORCID https://orcid.org/0000-0002-1367-1757
Mei-Chin LuGraduate Institute of Marine Biology, National Dong Hwa University, Hualien, Taiwan.ORCID https://orcid.org/0000-0003-4335-3837
Kai-Cheng HsuGraduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.ORCID https://orcid.org/0000-0002-9022-6673
Mohamed El-ShazlyDepartment of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Cairo, Egypt.ORCID https://orcid.org/0000-0003-0050-8288
Tsen-Ni TsaiGraduate Institute of Marine Biology, National Dong Hwa University, Hualien, Taiwan.ORCID https://orcid.org/0000-0002-1151-9305
Tzu-Yung LinDepartment and Graduate Institute of Aquaculture, National Kaohsiung University of Science and Technology, Kaohsiung, Taiwan.ORCID https://orcid.org/0000-0002-9034-4397
Shou-Ping ShihDoctoral Degree Program in Marine Biotechnology, National Sun Yat-Sen University, Kaohsiung, Taiwan.ORCID https://orcid.org/0000-0001-8989-5979
Tony Eight LinMaster Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.ORCID https://orcid.org/0000-0002-6267-0224
Zhi-Hong WenDepartment of Marine Biotechnology and Resources, National Sun Yat-Sen University, Kaohsiung, Taiwan.ORCID https://orcid.org/0000-0003-4411-044X
Yu-Chen S H YangJoint Biobank, Office of Human Research, Taipei Medical University, Taipei, Taiwan.ORCID https://orcid.org/0000-0002-7589-8527
Yi-Chang LiuDivision of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.ORCID https://orcid.org/0000-0002-0681-3796
National Sun Yat-sen University · TWKaohsiung Medical University · TWNational Kaohsiung Marine University · TWTaipei Medical University · TWAin Shams University · EGNational Dong Hwa University · TW

Funding

Kaohsiung Armed Forces General Hospital KAFGH_D_110031Kaohsiung Medical University Hospital KMUH DK(B)110001-3Ministry of Science and Technology MOST 107-2320-B-259-004-MY3Ministry of Science and Technology MOST 110-2314-B-037-083Ministry of Science and Technology MOST 110-2320-B259-001-MY3National Dong Hwa University 109T2560-5National Dong Hwa University 110T2560-5National Health Research Institutes NHRI-111A1-CACO-03222109
6 · The paper itself

Abstract

13-Acetoxysarcocrassolide (13-AC) is a marine cembranoid derived from the aquaculture soft coral of Lobophytum crassum. The cytotoxic effect of 13-AC against leukemia cells was previously reported but its mechanism of action is still unexplored. In the current study, we showed that 13-AC induced apoptosis of human acute lymphoblastic leukemia Molt4 cells, as evidenced by the cleavage of PARP and caspases, phosphatidylserine externalization, as well as the disruption of mitochondrial membrane potential. The use of N-acetylcysteine (NAC), a reactive oxygen species (ROS) scavenger, attenuated the cytotoxic effect induced by 13-AC. Molecular docking and thermal shift assay indicated that the cytotoxic mechanism of action of 13-AC involved the inhibition of heat shock protein 90 (Hsp 90) activity by eliciting the level of Hsp 70 and topoisomerase IIα in Molt4 cells. 13-AC also exhibited potent antitumor activity by reducing the tumor volume (48.3%) and weight (72.5%) in the in vivo Molt4 xenograft mice model. Our findings suggested that the marine cembranoid, 13-AC, acted as a dual inhibitor of Hsp 90 and topoisomerase IIα, exerting more potent apoptotic activity via the enhancement of ROS generation.

Indexed as

AnthozoaAntineoplastic AgentsAnimalsApoptosisCell Line, TumorDiterpenesDNA Topoisomerases, Type IIHeat-Shock ProteinsHumansMiceMolecular Docking SimulationOxidative StressReactive Oxygen Species13-acetoxysarcocrassolideAntineoplastic AgentsDiterpenesDNA Topoisomerases, Type IIHeat-Shock ProteinsReactive Oxygen Species13-Acetoxysarcocrassolideheat shock protein 90leukemiaoxidative stresstopoisomerase II

Identifiers

PMID37052190
PMCPMC11895965
OpenAlexW4365442845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.